In colorectal cancer, METTL3 promoted GLUT1 translation in an m6A-dependent manner, which resulted in downstream activation of mTORC1 and increased cell survival and proliferation (Chen et al., 2021). Here, SLC2A1 is linked to colorectal cancer.